Pravastatin improves endothelial function in arteries used in coronary bypass grafting

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 6, 2013, Pages 513-519

  Kassan, Modar ^a   Sevilla, María A ^a   González Santos, José M ^b   López Rodríguez, Javier ^c   Sorlí, María J Dalmau ^b   Codoñer, María Bueno ^b   Montero, María J ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c NONE

Author keywords

Coronary artery bypass grafting; Human arteries; Pravastatin; Vascular reactivity

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; MEVALONIC ACID; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PRAVASTATIN; SUPEROXIDE; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIAL ARTERY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MAMMARY ARTERIES; NITROPRUSSIDE; PHENYLEPHRINE; POSTOPERATIVE PERIOD; PRAVASTATIN; RADIAL ARTERY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84879889643     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31828bc863     Document Type: Article

References (47)

1. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI). Kolh P, Wijns W, Danchin N, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010;38 (suppl):S1-S52.
2. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360: 965-970.
3. Lytle BW, Loop FD, Cosgrove DM. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985;89: 248-258.
4. Loop FD, Lytle BW, Cosgrove DM. Influence of the internal-mammaryartery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314: 1-6.
5. Carpentier A, Guermonprez JL, Deloche A. The aorta to coronary radial artery bypass graft: a technique avoiding pathological changes in grafts. Ann Thorac Surg. 1973;16: 111-121.
6. Fisk RL, Brooks CH, Callaghan JC, et al. Experience with the radial artery graft for coronary artery bypass. Ann Thorac Surg. 1976;21: 513-518.
7. Acar C, Jebara VA, Portoghese M, et al. Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg. 1992;54: 652-659.
8. Cable DG, Caccitolo JA, Pearson PJ, et al. New approaches to prevention and treatment of radial artery graft vasospasm. Circulation. 1998;98: II15-II21.
9. Kobayashi J. Radial artery as a graft for coronary artery bypass grafting. Circ J. 2009;73: 1178-1183.
10. Weinschelbaum EE, Macchia A, Caramutti VM, et al. Myocardial revascularization with radial and mammary arteries: initial and mid-term results. Ann Thorac Surg. 2000;70: 1378-1383.
11. Amano A, Hirose H, Takahashi A, et al. Coronary artery bypass grafting using the radial artery: midterm results in a Japanese institute. Ann Thorac Surg. 2001;72: 120-125.
12. Tatoulis J, Royse AG, Buxton BF, et al. The radial artery in coronary surgery: a 5-year experience - clinical and angiographic results. Ann Thorac Surg. 2002;73: 143-147.
13. Manabe S, Sunamori M. Radial artery graft for coronary artery bypass surgery: biological characteristics and clinical outcome. J Card Surg. 2006;21:102-114;115.
14. Schulz E, Tsilimingas N, Rinze R, et al. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation. 2002;105: 1170-1175.
15. Duggan JA, Mong K, Tabrizchi R. The influence of calcium channel antagonists on isolated human distal radial arteries. J Cardiovasc Pharmacol. 2003;42: 629-635.
16. Ding R, Feng W, Li H, et al. A comparative study on in vitro and in vivo effects of topical vasodilators in human internal mammary, radial artery and great saphenous vein. Eur J Cardiothorac Surg. 2008;34: 536-541.
17. Lazar HL, Bao Y, Zhang Y, et al. Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg. 2003;125: 1037-1042.
18. Campeau L. Lipid lowering and coronary bypass graft surgery. Curr Opin Cardiol. 2000;15: 395-399.
19. Kulik A, Ruel M. Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits? Curr Opin Cardiol. 2011;26: 508-517.
20. Bouchard D, Carrier M, Demers P, et al. Statin in combination with betablocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. Ann Thorac Surg. 2011;91: 654-659.
21. Sun Y, Ji Q, Mei Y, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. 2011;52: 7-11.
22. Kassan M, Montero MJ, Sevilla MA. In vitro antioxidant activity of pravastatin provides vascular protection. Eur J Pharmacol. 2010;630: 107-111.
23. Kassan M, Montero MJ, Sevilla MA. Chronic treatment with pravastatin prevents early cardiovascular changes in spontaneously hypertensive rats. Br J Pharmacol. 2009;158: 541-547.
24. Metcalfe MJ, Lip GY, Dargie HJ. Factors influencing coronary artery bypass graft patency. Cardiovasc Surg. 1994;2: 679-685.
25. Buxton BF, Hayward PA, Newcomb AE, et al. Choice of conduits for coronary artery bypass grafting: craft or science? Eur J Cardiothorac Surg. 2009;35: 658-670.
26. Nakamura K, Al-Ruzzeh S, Chester AH, et al. Effects of cerivastatin on vascular function of human radial and left internal thoracic arteries. Ann Thorac Surg. 2002;73: 1860-1865.
27. van Son JA, Smedts F, Vincent JG, et al. Comparative anatomic studies of various arterial conduits for myocardial revascularization. J Thorac Cardiovasc Surg. 1990;99: 703-707.
28. Chamiot-Clerc P, Copie X, Renaud JF, et al. Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries. Cardiovasc Res. 1998;37: 811-819.
29. Arshad M, Vijay V, Floyd BC, et al. Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries. Ann Thorac Surg. 2006;81: 2147-2154.
30. Teoh KH, Fremes SE, Weisel RD, et al. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization. J Thorac Cardiovasc Surg. 1987;93: 120-126.
31. Sametz W, Metzler H, Gries M, et al. Perioperative catecholamine changes in cardiac risk patients. Eur J Clin Invest. 1999;29: 582-587.
32. Chardigny C, Jebara VA, Acar C, et al. Vasoreactivity of the radial artery. Comparison with the internal mammary and gastroepiploic arteries with implications for coronary artery surgery. Circulation. 1993; 88:II115-II127.
33. He GW, Yang CQ, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg. 1995;59: 676-683.
34. He GW, Yang CQ. Radial artery has higher receptor-mediated contractility but similar endothelial function compared with mammary artery. Ann Thorac Surg. 1997;63: 1346-1352.
35. Chardigny CI, Van der Perre K, Simonet S, et al. Platelets and prostacyclin in arterial bypasses: implications for coronary artery surgery. Ann Thorac Surg. 2000;69: 513-519.
36. Cable DG, Caccitolo JA, Pfeifer EA, et al. Endothelial regulation of vascular contraction in radial and internal mammary arteries. Ann Thorac Surg. 1999;67: 1083-1090.
37. Grapow MT, Reineke DC, Kern T, et al. Intraindividual comparison of human radial and internal thoracic arteries in vitro and the effect of preoperative calcium blocker therapy. Fundam Clin Pharmacol. 2007; 21: 67-74.
38. Shapira OM, Xu A, Aldea GS, et al. Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with internal mammary artery or saphenous vein. Circulation. 1999;100:II322-II327.
39. He GW, Fan L, Grove KL, et al. Expression and function of endothelial nitric oxide synthase messenger RNA and protein are higher in internal mammary than in radial arteries. Ann Thorac Surg. 2011;92: 845-850.
40. Mehlhorn U, Krahwinkel A, Geissler HJ, et al. Nitrotyrosine and 8- isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg. 2003;125: 178-183.
41. Cavalca V, Sisillo E, Veglia F, et al. Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery. Ann Thorac Surg. 2006;81: 562-567.
42. Kun X, Lefeng W, Rongjing D, et al. RhoA/ROK pathway related to the mechanism of higher susceptibility to spasm in RA than in IMA. J Card Surg. 2009;24: 766-771.
43. Yang Z, Kozai T, van der Loo B, et al. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. J Am Coll Cardiol. 2000;36: 1691-1697.
44. Zhou R, Xu Q, Zheng P, et al. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur J Pharmacol. 2008;586: 244-250.
45. Nakamura K, Al-Ruzzeh S, Chester AH, et al. Differential effect of cerivastatin and L-arginine on the vascular function of human radial and left internal thoracic arteries. J Card Surg. 2005;20: 22-28.
46. Nakamura K, Al-Ruzzeh S, Chester AH, et al. Differential in vitro response of the human radial artery versus left internal thoracic artery to cerivastatin: implications to bypass grafting. Ann Thorac Surg. 2003; 76: 2023-2028.
47. Berry C, Hamilton CA, Brosnan MJ, et al. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation. 2000; 101: 2206-2212.